Allscripts purchased a 10 percent equity stake in NantHealth for $200 million cash, and NantCapital, the investment arm of NantHealth, invested $100 million in Allscripts.
The investments seek to strengthen the strategic alliance between the two companies, announced in March 2015, focused on developing and providing precision medicine solutions, leveraging Allscripts’ global network of clients and software solutions as well as NantHealth’s clinical platform and connectivity devices.
“We’re taking an important step forward in our strategic partnership that fully aligns our resources and furthers Allscripts’ strategy to invest in new technologies that can revolutionize service to hospitals and physicians,” said Paul Black, president and CEO of Allscripts, in a statement. “We’re confident that our joint efforts will help Allscripts lead the way in our vision of delivering an open, integrated and precision-based medical solutions to physicians and patients.”
More articles on health IT:
12 standout CIOs | Part 2
50 biggest data breaches in healthcare
How long do physicians spend charting on EHRs each day?
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.